Showing results 1 to 20 of 52
next >
| Issue Date | Title | Author(s) |
| 2023-09 | Family communication and results disclosure after germline sequencing: A mixed methods study. | Harrison, C; Bartley, N; Jacobs, C; Best, M; Vatter, S; Meiser, B; Ballinger, ML; Thomas, DM; Butow, P; members of the PiGeOn Project, |
| 2023-06 | Vaccine hesitancy in cancer patients: A rapid review. | Butow, P; Shaw, J; Bartley, N; Milch, V; Sathiaraj, R; Turnbull, S; Der Vartanian, C |
| 2023-05-22 | Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial. | Butow, P; Faris, MM; Shaw, J; Kelly, P; He, S; Harris, M; Cuddy, J; Masya, L; Geerligs, L; Kelly, B; Girgis, A; Rankin, N; Beale, P; Hack, TF; Kirsten, L; Dhillon, H; Grimison, P; Viney, R; Clayton, JM; Schlub, T; ADAPT Program Group,; Shepherd, HL |
| 2022-10 | Validation of the Knowledge of Genome Sequencing (KOGS) scale in cancer patients. | Butow, P; Napier, C; Campbell, R; Bartley, N; Best, M; Ballinger, ML |
| 2022-10 | Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study. | Best, MC; Bartley, N; Napier, CE; Fisher, A; Ballinger, ML; Thomas, DM; Goldstein, D; Tucker, K; Biesecker, BB; Butow, P |
| 2022-08 | Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting. | Best, MC; Butow, P; Savard, J; Jacobs, C; Bartley, N; Davies, G; Napier, CE; Ballinger, ML; Thomas, DM; Biesecker, B; Tucker, KM; Juraskova, I; Meiser, B; Schlub, T; Newson, AJ |
| 2022-07-18 | Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination. | Bartley, N; Havard, P; Butow, P; Shaw, J; COVID-19 Cancer Stakeholder Authorship Group, |
| 2022-07 | Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results. | Best, M; Napier, C; Schlub, T; Bartley, N; Biesecker, B; Ballinger, M; Butow, P |
| 2022-06 | Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results. | Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Best, MC; members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project,; Jacobs, C |
| 2022-06 | Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results. | Vatter, S; Schlub, TE; Napier, CE; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, BB; Goldstein, D; Thomas, DM; Butow, P; Members of the PiGeOn Project, |
| 2022-02-14 | Staff perspectives on the feasibility of a clinical pathway for anxiety and depression in cancer care, and mid-implementation adaptations. | Butow, P; Shepherd, HL; Cuddy, J; Rankin, N; Harris, M; He, S; Grimison, P; Girgis, A; Faris, M; ADAPT Program Group,; Shaw, J |
| 2022-02 | Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study. | Butow, P; Davies, G; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, T; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project, |
| 2022-02 | Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients. | Bartley, N; Best, MC; Biesecker, BB; Fisher, A; Goldstein, D; Meiser, B; Thomas, DM; Ballinger, ML; Butow, P |
| 2022-01-31 | Development, acceptability and uptake of an on-line communication skills education program targeting challenging conversations for oncology health professionals related to identifying and responding to anxiety and depression. | Shaw, J; Allison, K; Cuddy, J; Lindsay, T; Grimison, P; Shepherd, H; Butow, P; Shaw, T; Baychek, K; ADAPT Program Group,; Kelly, B |
| 2021-11-17 | Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives. | Butow, P; Shepherd, HL; Cuddy, J; Harris, M; He, S; Masya, L; Faris, M; Rankin, NM; Beale, P; Girgis, A; Kelly, B; Grimison, P; ADAPT Program Group,; Shaw, J |
| 2021-11-10 | Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling. | Meiser, B; Butow, P; Davies, G; Napier, CE; Schlub, TE; Bartley, N; Juraskova, I; Ballinger, ML; Thomas, DM; Tucker, K; Goldstein, D; Biesecker, BB; Best, MC; Members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project, |
| 2021-11 | Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling. | Butow, P; Müller, F; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, TE; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project, |
| 2021-09-14 | Uptake of an online psychological therapy program (iCanADAPT-Early) when implemented within a clinical pathway in cancer care centres. | Davies, F; Harris, M; Shaw, J; Butow, P; Newby, J; Murphy, M; Kirsten, L; ADAPT Program Group,; Shepherd, HL |
| 2021-08 | Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study. | Bartley, N; Best, M; Butow, P |
| 2021-07-26 | Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative study | Vatter, S; Bartley, N; Best, M; Juraskova, I; Jacobs, C; Ballinger, ML; Thomas, DM; Butow, P |
